JP2012512909A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012512909A5 JP2012512909A5 JP2011542518A JP2011542518A JP2012512909A5 JP 2012512909 A5 JP2012512909 A5 JP 2012512909A5 JP 2011542518 A JP2011542518 A JP 2011542518A JP 2011542518 A JP2011542518 A JP 2011542518A JP 2012512909 A5 JP2012512909 A5 JP 2012512909A5
- Authority
- JP
- Japan
- Prior art keywords
- umbilical cord
- cell population
- cord tissue
- derived
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims description 41
- 210000001519 tissue Anatomy 0.000 claims description 36
- 210000003954 umbilical cord Anatomy 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 20
- 108010017842 Telomerase Proteins 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 208000004296 neuralgia Diseases 0.000 claims description 7
- 208000021722 neuropathic pain Diseases 0.000 claims description 7
- 208000002193 Pain Diseases 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 210000000130 stem cell Anatomy 0.000 claims description 3
- 208000028389 Nerve injury Diseases 0.000 claims description 2
- 230000008764 nerve damage Effects 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 16
- 239000003085 diluting agent Substances 0.000 claims 7
- 229940079593 drug Drugs 0.000 claims 7
- 239000003937 drug carrier Substances 0.000 claims 7
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 229950003499 fibrin Drugs 0.000 claims 4
- 208000000094 Chronic Pain Diseases 0.000 claims 3
- 108010035532 Collagen Proteins 0.000 claims 3
- 102000008186 Collagen Human genes 0.000 claims 3
- 206010010904 Convulsion Diseases 0.000 claims 3
- 229920001436 collagen Polymers 0.000 claims 3
- 230000036461 convulsion Effects 0.000 claims 3
- 239000000017 hydrogel Substances 0.000 claims 3
- 108010073385 Fibrin Proteins 0.000 claims 2
- 102000009123 Fibrin Human genes 0.000 claims 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000012062 aqueous buffer Substances 0.000 claims 2
- 108010045569 atelocollagen Proteins 0.000 claims 2
- 239000002612 dispersion medium Substances 0.000 claims 2
- 238000002513 implantation Methods 0.000 claims 2
- 230000001537 neural effect Effects 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- -1 thrombin-fibrin Substances 0.000 claims 2
- 230000009772 tissue formation Effects 0.000 claims 2
- 230000008467 tissue growth Effects 0.000 claims 2
- 208000007101 Muscle Cramp Diseases 0.000 claims 1
- 208000005392 Spasm Diseases 0.000 claims 1
- 210000000577 adipose tissue Anatomy 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 claims 1
- 210000002808 connective tissue Anatomy 0.000 claims 1
- 210000003041 ligament Anatomy 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 210000002435 tendon Anatomy 0.000 claims 1
- 229960004072 thrombin Drugs 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- 238000003752 polymerase chain reaction Methods 0.000 description 4
- 102000019034 Chemokines Human genes 0.000 description 3
- 108010012236 Chemokines Proteins 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 102100036153 C-X-C motif chemokine 6 Human genes 0.000 description 2
- 102000004890 Interleukin-8 Human genes 0.000 description 2
- 108090001007 Interleukin-8 Proteins 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 241001535291 Analges Species 0.000 description 1
- 102100034608 Angiopoietin-2 Human genes 0.000 description 1
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
- 102100021943 C-C motif chemokine 2 Human genes 0.000 description 1
- 101710155857 C-C motif chemokine 2 Proteins 0.000 description 1
- 101710085504 C-X-C motif chemokine 6 Proteins 0.000 description 1
- 108010014423 Chemokine CXCL6 Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 101710115997 Gamma-tubulin complex component 2 Proteins 0.000 description 1
- 102400001369 Heparin-binding EGF-like growth factor Human genes 0.000 description 1
- 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 1
- 101000924533 Homo sapiens Angiopoietin-2 Proteins 0.000 description 1
- 101001066129 Homo sapiens Glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 101000669513 Homo sapiens Metalloproteinase inhibitor 1 Proteins 0.000 description 1
- 101000830570 Homo sapiens Tumor necrosis factor alpha-induced protein 3 Proteins 0.000 description 1
- 101000955962 Homo sapiens Vacuolar protein sorting-associated protein 51 homolog Proteins 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 102100039364 Metalloproteinase inhibitor 1 Human genes 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102100022647 Reticulon-1 Human genes 0.000 description 1
- 101710122684 Reticulon-1 Proteins 0.000 description 1
- 102100032938 Telomerase reverse transcriptase Human genes 0.000 description 1
- 206010043276 Teratoma Diseases 0.000 description 1
- 102000011117 Transforming Growth Factor beta2 Human genes 0.000 description 1
- 101800000304 Transforming growth factor beta-2 Proteins 0.000 description 1
- 102100024596 Tumor necrosis factor alpha-induced protein 3 Human genes 0.000 description 1
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000002798 bone marrow cell Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 108010007093 dispase Proteins 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 102000047486 human GAPDH Human genes 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 1
- 229940096397 interleukin-8 Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 210000005087 mononuclear cell Anatomy 0.000 description 1
- 230000007433 nerve pathway Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000011476 stem cell transplantation Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 108010057210 telomerase RNA Proteins 0.000 description 1
- 230000002381 testicular Effects 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13916908P | 2008-12-19 | 2008-12-19 | |
| US61/139,169 | 2008-12-19 | ||
| PCT/US2009/068879 WO2010071862A1 (en) | 2008-12-19 | 2009-12-19 | Umbilical cord tissue derived cells for treating neuropathic pain and spasticity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012512909A JP2012512909A (ja) | 2012-06-07 |
| JP2012512909A5 true JP2012512909A5 (cg-RX-API-DMAC7.html) | 2012-07-19 |
| JP5646502B2 JP5646502B2 (ja) | 2014-12-24 |
Family
ID=41682583
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011542518A Expired - Fee Related JP5646502B2 (ja) | 2008-12-19 | 2009-12-19 | 神経因性疼痛を治療するための臍帯組織由来細胞 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20190105351A9 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2379087B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5646502B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102481321B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2009327382B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0923177A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2747757C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1116344T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK2379087T3 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2520393T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT2379087E (cg-RX-API-DMAC7.html) |
| SI (1) | SI2379087T1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2010071862A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7875272B2 (en) * | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
| US9592258B2 (en) | 2003-06-27 | 2017-03-14 | DePuy Synthes Products, Inc. | Treatment of neurological injury by administration of human umbilical cord tissue-derived cells |
| US8518390B2 (en) | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
| US8491883B2 (en) * | 2003-06-27 | 2013-07-23 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of amyotrophic lateral sclerosis using umbilical derived cells |
| PL1641916T3 (pl) | 2003-06-27 | 2016-08-31 | Depuy Synthes Products Inc | Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych |
| US8790637B2 (en) | 2003-06-27 | 2014-07-29 | DePuy Synthes Products, LLC | Repair and regeneration of ocular tissue using postpartum-derived cells |
| CA2623940C (en) | 2005-09-27 | 2017-01-10 | Tissuetech, Inc. | Amniotic membrane preparations and purified compositions and methods of use |
| US9125906B2 (en) | 2005-12-28 | 2015-09-08 | DePuy Synthes Products, Inc. | Treatment of peripheral vascular disease using umbilical cord tissue-derived cells |
| CN101611139B (zh) | 2006-11-13 | 2012-07-04 | 伊西康公司 | 利用微载体的产后来源的细胞的体外扩增 |
| CN102036688B (zh) * | 2007-10-05 | 2014-07-02 | 伊西康公司 | 使用人脐带组织来源的细胞进行肾脏组织的修复和再生 |
| US8236538B2 (en) | 2007-12-20 | 2012-08-07 | Advanced Technologies And Regenerative Medicine, Llc | Methods for sterilizing materials containing biologically active agents |
| AU2009327384B2 (en) | 2008-12-19 | 2014-07-10 | DePuy Synthes Products, LLC | Treatment of lung and pulmonary diseases and disorders |
| US10179900B2 (en) | 2008-12-19 | 2019-01-15 | DePuy Synthes Products, Inc. | Conditioned media and methods of making a conditioned media |
| EP2411504B1 (en) * | 2009-03-26 | 2017-05-10 | DePuy Synthes Products, Inc. | Human umbilical cord tissue cells as therapy for alzheimer's disease |
| WO2012149486A1 (en) | 2011-04-28 | 2012-11-01 | Tissuetech, Inc. | Methods of modulating bone remodeling |
| EP2714059B1 (en) * | 2011-06-01 | 2018-10-03 | Celularity, Inc. | Treatment of pain using placental stem cells |
| JP5937210B2 (ja) * | 2011-08-10 | 2016-06-22 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | 臍帯組織由来細胞を用いた末梢血管疾患の治療 |
| JP2015521630A (ja) * | 2012-06-26 | 2015-07-30 | ラスティー プロパティー ホールディングス プロプライエタリー リミテッド | 頭痛の頻度および／または重症度を下げるための組成物および方法 |
| EP2756754B1 (de) | 2013-01-17 | 2017-01-04 | Vita 34 Ag | Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes |
| US10039792B1 (en) * | 2013-03-16 | 2018-08-07 | Brahm Holdings, Llc | Methods for the treatment of inflammation and pain using human birth tissue material composition |
| SG11201700753YA (en) * | 2014-07-29 | 2017-02-27 | Ingeneron Inc | Method and apparatus for recovery of umbilical cord tissue derived regenerative cells and uses thereof |
| US20160243288A1 (en) | 2015-02-23 | 2016-08-25 | Tissuetech, Inc. | Apparatuses and methods for treating ophthalmic diseases and disorders |
| CN106906180A (zh) * | 2016-12-28 | 2017-06-30 | 里程 | 一种具有生物活化作用的复合添加剂及其制备方法和用途 |
| WO2019213518A1 (en) * | 2018-05-04 | 2019-11-07 | Figene, Llc | Pain-reducing effects of fibroblasts and treatment of pain |
| CN110772535A (zh) * | 2018-07-12 | 2020-02-11 | 南通大学 | 多系分化持续应激细胞在制备镇痛药物中的应用 |
| US12441984B2 (en) | 2019-11-08 | 2025-10-14 | Kansas State University Research Foundation | Isolation, preservation, and expansion of canine umbilical cord mesenchymal stromal cells |
| CN112190694B (zh) * | 2020-09-17 | 2023-11-10 | 南通大学 | 细胞因子活化素c在治疗神经病理性疼痛方面的应用 |
| US20220280573A1 (en) * | 2021-03-03 | 2022-09-08 | Axogen Corporation | Human umbilical cord-derived compositions and uses thereof for treating neuropathy |
| WO2022186946A1 (en) * | 2021-03-03 | 2022-09-09 | Axogen Corporation | Human umbilical cord-derived compositions and uses thereof for treating neuropathy |
| CN114561355B (zh) * | 2022-01-23 | 2023-04-11 | 四川大学华西医院 | 一种脊髓瘢痕组织细胞急性快速分离方法 |
| WO2024025912A2 (en) * | 2022-07-26 | 2024-02-01 | Biostem Technologies, Inc. | Human umbilical cord compositions and methods for intra-articular therapy |
Family Cites Families (98)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3665061A (en) * | 1969-07-16 | 1972-05-23 | United States Banknote Corp | Process for producing collagen sponges |
| JPS5651747B2 (cg-RX-API-DMAC7.html) * | 1973-05-31 | 1981-12-08 | ||
| US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
| US5902741A (en) * | 1986-04-18 | 1999-05-11 | Advanced Tissue Sciences, Inc. | Three-dimensional cartilage cultures |
| US5192553A (en) * | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
| US5004681B1 (en) * | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
| US20030032178A1 (en) * | 1988-08-04 | 2003-02-13 | Williams Robert Lindsay | In vitro propagation of embryonic stem cells |
| US4925677A (en) * | 1988-08-31 | 1990-05-15 | Theratech, Inc. | Biodegradable hydrogel matrices for the controlled release of pharmacologically active agents |
| US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5286632A (en) * | 1991-01-09 | 1994-02-15 | Jones Douglas H | Method for in vivo recombination and mutagenesis |
| US6399369B1 (en) * | 1991-07-08 | 2002-06-04 | Neurospheres Holdings Ltd. | Multipotent neural stem cell cDNA libraries |
| US5320962A (en) * | 1992-07-22 | 1994-06-14 | Duke University | DNA encoding the human A1 adenosine receptor |
| US5955343A (en) | 1992-12-28 | 1999-09-21 | Massachusetts Institute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| US5670483A (en) | 1992-12-28 | 1997-09-23 | Massachusetts Insititute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| US5707643A (en) * | 1993-02-26 | 1998-01-13 | Santen Pharmaceutical Co., Ltd. | Biodegradable scleral plug |
| JP3680114B2 (ja) * | 1993-09-17 | 2005-08-10 | 敏一 中村 | 脳神経障害治療剤 |
| US6686198B1 (en) * | 1993-10-14 | 2004-02-03 | President And Fellows Of Harvard College | Method of inducing and maintaining neuronal cells |
| US6703017B1 (en) * | 1994-04-28 | 2004-03-09 | Ixion Biotechnology, Inc. | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
| EP0952792B1 (en) * | 1994-06-06 | 2003-08-27 | Case Western Reserve University | Biomatrix for tissue regeneration |
| US6309853B1 (en) | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| US5725493A (en) * | 1994-12-12 | 1998-03-10 | Avery; Robert Logan | Intravitreal medicine delivery |
| US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
| US5869079A (en) * | 1995-06-02 | 1999-02-09 | Oculex Pharmaceuticals, Inc. | Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents |
| US5641750A (en) * | 1995-11-29 | 1997-06-24 | Amgen Inc. | Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product |
| US6200606B1 (en) * | 1996-01-16 | 2001-03-13 | Depuy Orthopaedics, Inc. | Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| US6358737B1 (en) * | 1996-07-31 | 2002-03-19 | Board Of Regents, The University Of Texas System | Osteocyte cell lines |
| US6787355B1 (en) * | 1996-08-26 | 2004-09-07 | Mcgill University | Multipotent neural stem cells from peripheral tissues and uses thereof |
| CA2290381A1 (en) * | 1997-05-21 | 1998-11-26 | Sloan-Kettering Institute For Cancer Research | Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| AU738334B2 (en) * | 1997-05-30 | 2001-09-13 | Osteobiologics, Inc. | Fiber-reinforced, porous, biodegradable implant device |
| US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
| AU1615599A (en) * | 1997-12-02 | 1999-06-16 | Zen Bio, Inc. | Differentiation of adipose stromal cells into osteoblasts and uses thereof |
| US6059968A (en) * | 1998-01-20 | 2000-05-09 | Baxter International Inc. | Systems for processing and storing placenta/umbilical cord blood |
| AU749675B2 (en) * | 1998-03-13 | 2002-07-04 | Mesoblast International Sarl | Uses for human non-autologous mesenchymal stem cells |
| US6171610B1 (en) * | 1998-04-24 | 2001-01-09 | University Of Massachusetts | Guided development and support of hydrogel-cell compositions |
| WO1999056759A1 (en) * | 1998-05-07 | 1999-11-11 | University Of South Florida | Bone marrow cells as a source of neurons for brain and spinal cord repair |
| US6387367B1 (en) * | 1998-05-29 | 2002-05-14 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US20040037818A1 (en) * | 1998-07-30 | 2004-02-26 | Brand Stephen J. | Treatment for diabetes |
| US5958767A (en) * | 1998-08-14 | 1999-09-28 | The Children's Medical Center Corp. | Engraftable human neural stem cells |
| US6610540B1 (en) * | 1998-11-18 | 2003-08-26 | California Institute Of Technology | Low oxygen culturing of central nervous system progenitor cells |
| US20030007954A1 (en) * | 1999-04-12 | 2003-01-09 | Gail K. Naughton | Methods for using a three-dimensional stromal tissue to promote angiogenesis |
| CA2370330C (en) | 1999-04-16 | 2009-01-20 | Wm. Marsh Rice University | Biodegradable poly(propylene fumarate) networks cross linked with poly(propylene fumarate)-diacrylate macromers |
| US6287340B1 (en) * | 1999-05-14 | 2001-09-11 | Trustees Of Tufts College | Bioengineered anterior cruciate ligament |
| US6372494B1 (en) * | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
| US6355699B1 (en) | 1999-06-30 | 2002-03-12 | Ethicon, Inc. | Process for manufacturing biomedical foams |
| US6333029B1 (en) * | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
| US6555374B1 (en) * | 1999-08-19 | 2003-04-29 | Artecel Sciences, Inc. | Multiple mesodermal lineage differentiation potentials for adipose tissue-derived stromal cells and uses thereof |
| US20030129745A1 (en) * | 1999-10-28 | 2003-07-10 | Robl James M. | Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| JP2003523323A (ja) * | 1999-12-06 | 2003-08-05 | ザ ジェネラル ホスピタル コーポレーション | 膵臓幹細胞および移植におけるその使用 |
| US20030082155A1 (en) * | 1999-12-06 | 2003-05-01 | Habener Joel F. | Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| US7544509B2 (en) * | 2000-01-24 | 2009-06-09 | Mcgill University | Method for preparing stem cell preparations |
| AU2001243464B2 (en) * | 2000-03-09 | 2006-04-13 | Saneron Ccel Therapeutics, Inc. | Human cord blood as a source of neural tissue for repair of the brain and spinal cord |
| US6673606B1 (en) * | 2000-04-12 | 2004-01-06 | The Children's Hospital Of Philadelphia | Therapeutic uses for mesenchymal stromal cells |
| US6375972B1 (en) * | 2000-04-26 | 2002-04-23 | Control Delivery Systems, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| US6759039B2 (en) * | 2000-06-30 | 2004-07-06 | Amcyte, Inc. | Culturing pancreatic stem cells having a specified, intermediate stage of development |
| ATE419333T1 (de) | 2001-02-06 | 2009-01-15 | Massachusetts Inst Technology | Peptidgerüstverkapselung von gewebszellen und verwendungen davon |
| US7449180B2 (en) | 2001-02-06 | 2008-11-11 | John Kisiday | Macroscopic scaffold containing amphiphilic peptides encapsulating cells |
| EP2336299A1 (en) * | 2001-02-14 | 2011-06-22 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
| SG125066A1 (en) * | 2001-04-19 | 2006-09-29 | Lintec Corp | Adhesive sheet for precision electronic member |
| US20030022369A1 (en) * | 2001-05-18 | 2003-01-30 | Helen Fillmore | Differentiation of specialized dermal and epidermal cells into neuronal cells |
| JP2005515753A (ja) * | 2001-05-25 | 2005-06-02 | サイセラ，インコーポレイテッド | 幹細胞分化 |
| US6835711B2 (en) * | 2001-06-28 | 2004-12-28 | Yeda Research And Development Co. Ltd. | Use of poly-Glu,Tyr for neuroprotective therapy |
| WO2003018767A2 (en) * | 2001-08-27 | 2003-03-06 | Advanced Cell Technology, Inc. | Trans-differentiation and re-differentiation of somatic cells and production of cells for cell therapies |
| US20030104997A1 (en) * | 2001-09-05 | 2003-06-05 | Black Ira B. | Multi-lineage directed induction of bone marrow stromal cell differentiation |
| US9969980B2 (en) | 2001-09-21 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| US7129034B2 (en) * | 2001-10-25 | 2006-10-31 | Cedars-Sinai Medical Center | Differentiation of whole bone marrow |
| JP3728750B2 (ja) * | 2001-11-22 | 2005-12-21 | ニプロ株式会社 | 培養皮膚及びその製造方法 |
| EP1458854B1 (en) * | 2001-12-21 | 2010-04-14 | Mount Sinai Hospital | Cellular compositions and methods of making and using them |
| US20030162290A1 (en) * | 2002-01-25 | 2003-08-28 | Kazutomo Inoue | Method for inducing differentiation of embryonic stem cells into functioning cells |
| US20040029269A1 (en) * | 2002-05-07 | 2004-02-12 | Goldman Steven A | Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells |
| AU2003233119A1 (en) * | 2002-05-08 | 2003-11-11 | Neuronova Ab | Modulation of neural stem cells with s1p or lpa receptor agonists |
| KR20050008757A (ko) * | 2002-05-30 | 2005-01-21 | 셀진 코포레이션 | 세포 분화를 조절하고 골수증식성 질환 및 골수형성이상증후군을 치료하기 위하여 ｊｎｋ 또는 ｍｋｋ 저해제를사용하는 방법 |
| US7410797B2 (en) * | 2002-06-11 | 2008-08-12 | Ogle Roy C | Meningeal-derived stem cells |
| US7285415B2 (en) * | 2002-07-11 | 2007-10-23 | The Regents Of The University Of California | Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| US7390659B2 (en) * | 2002-07-16 | 2008-06-24 | The Trustees Of Columbia University In The City Of New York | Methods for inducing differentiation of embryonic stem cells and uses thereof |
| EP1543111A4 (en) * | 2002-08-28 | 2006-09-13 | Univ Florida | NEUROGENESIS FROM HEPATIC STEM CELLS |
| US9969977B2 (en) | 2002-09-20 | 2018-05-15 | Garnet Biotherapeutics | Cell populations which co-express CD49c and CD90 |
| CA2515594A1 (en) * | 2003-02-13 | 2004-08-26 | Anthrogenesis Corporation | Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
| US7875272B2 (en) * | 2003-06-27 | 2011-01-25 | Ethicon, Incorporated | Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells |
| PL1641916T3 (pl) * | 2003-06-27 | 2016-08-31 | Depuy Synthes Products Inc | Regeneracja i naprawa tkanki nerwowej z wykorzystaniem komórek poporodowych |
| US8518390B2 (en) * | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
| US20050089513A1 (en) * | 2003-10-28 | 2005-04-28 | Norio Sakuragawa | Side population cells originated from human amnion and their uses |
| IN2014CN03629A (cg-RX-API-DMAC7.html) * | 2004-11-17 | 2015-09-04 | Neuralstem Inc | |
| AU2005308396B2 (en) * | 2004-11-29 | 2011-06-09 | Yeda Research And Development Co. Ltd. | Induction of neurogenesis and stem cell therapy in combination with Copolymer 1 |
| US7833513B2 (en) * | 2004-12-03 | 2010-11-16 | Rhode Island Hospital | Treatment of Alzheimer's Disease |
| WO2006071778A2 (en) * | 2004-12-23 | 2006-07-06 | Ethicon Incorporated | Treatment of parkinson's disease and related disorders using postpartum derived cells |
| GB2440089B8 (en) * | 2005-05-05 | 2012-09-05 | Univ Goettingen Georg August | Regeneration system, its production and use |
| WO2007016245A2 (en) * | 2005-07-29 | 2007-02-08 | Vivicells International, Llc | Reprogramming of adult or neonic stem cells and methods of use |
| AU2006236006B2 (en) * | 2006-04-13 | 2012-09-06 | The University Of Queensland | Cyclised a-conotoxin peptides |
| CA2893679C (en) * | 2006-06-26 | 2018-10-30 | Lifescan, Inc. | Conditioned medium for pluripotent stem cell culture |
| US8372399B2 (en) * | 2006-08-31 | 2013-02-12 | Cardiac Pacemakers, Inc. | Bispecific antibodies and agents to enhance stem cell homing |
| DK2078073T3 (da) * | 2006-10-12 | 2013-10-28 | Ethicon Inc | Nyreafledte celler og fremgangsmåder til anvendelse deraf til vævsreparation og -regenerering |
| US20080092653A1 (en) * | 2006-10-18 | 2008-04-24 | Scintrex Limited | Method of reducing the drift rate of accelerometer and accelerometer with reduced drift rate |
| WO2008085221A2 (en) * | 2006-10-27 | 2008-07-17 | Caritas St. Elizabeth Medical Center Of Boston, Inc. | Therapeutic use of cd31 expressing cells |
| CN101657206B (zh) * | 2007-02-12 | 2013-07-03 | 人类起源公司 | 利用胎盘干细胞治疗炎性疾病 |
| US20080305148A1 (en) * | 2007-03-19 | 2008-12-11 | National Yang Ming University | Treatment of spinal injuries using human umbilical mesenchymal stem cells |
| EP2237789B1 (en) * | 2007-12-27 | 2017-01-25 | DePuy Synthes Products, Inc. | Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells |
| EP2411504B1 (en) * | 2009-03-26 | 2017-05-10 | DePuy Synthes Products, Inc. | Human umbilical cord tissue cells as therapy for alzheimer's disease |
-
2009
- 2009-12-19 JP JP2011542518A patent/JP5646502B2/ja not_active Expired - Fee Related
- 2009-12-19 DK DK09795654.4T patent/DK2379087T3/da active
- 2009-12-19 US US12/642,775 patent/US20190105351A9/en not_active Abandoned
- 2009-12-19 PT PT97956544T patent/PT2379087E/pt unknown
- 2009-12-19 EP EP09795654.4A patent/EP2379087B1/en not_active Not-in-force
- 2009-12-19 WO PCT/US2009/068879 patent/WO2010071862A1/en not_active Ceased
- 2009-12-19 CN CN200980156986.9A patent/CN102481321B/zh not_active Expired - Fee Related
- 2009-12-19 BR BRPI0923177-3A patent/BRPI0923177A2/pt not_active Application Discontinuation
- 2009-12-19 SI SI200931065T patent/SI2379087T1/sl unknown
- 2009-12-19 AU AU2009327382A patent/AU2009327382B2/en not_active Ceased
- 2009-12-19 CA CA2747757A patent/CA2747757C/en active Active
- 2009-12-19 ES ES09795654.4T patent/ES2520393T3/es active Active
-
2014
- 2014-11-18 CY CY20141100961T patent/CY1116344T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012512909A5 (cg-RX-API-DMAC7.html) | ||
| JP2012512911A5 (cg-RX-API-DMAC7.html) | ||
| JP2010540662A5 (cg-RX-API-DMAC7.html) | ||
| KR101914918B1 (ko) | 인간 제대 조직-유래된 세포 및 하이드로겔을 이용한 추간판 퇴화의 치료 | |
| CN104955470B (zh) | 利用了hmgb1片段的针对脊髄损伤的新型治疗方法 | |
| EP3299451B1 (en) | Methods of using adipose tissue-derived cells in the treatment of raynaud's phenomenon | |
| DE102017002458B4 (de) | Von adipösem gewebe stammende stromale stammzellen zur verwendung bei der behandlung behandlungsresistenter komplexer perianalfisteln bei morbus crohn | |
| CN101792737A (zh) | 低氧间充质干细胞的培养方法、用途及组合制剂 | |
| CN110612307B (zh) | 用于诱导组织再生的肽及其应用 | |
| JP6399410B2 (ja) | 幹細胞の治療可能性を高めるための組成物および方法 | |
| KR20180009435A (ko) | 지방조직-유래 기질혈관분획의 분리 방법 | |
| CN103740641A (zh) | 一种诱导人脂肪间充质干细胞分化为胰岛样细胞的培养基及其诱导方法 | |
| KR102729581B1 (ko) | Ｆｇｆ２－ｒｇｄ 융합 단백질을 포함하는 줄기세포의 연골세포로의 분화용 조성물 | |
| CN114276980A (zh) | 一种培养适合临床应用的胰岛细胞的方法 | |
| JP2022503847A (ja) | 治療適用のための骨髄由来ニューロキニン－１受容体陽性（ｎｋ１ｒ＋）前駆細胞 | |
| EP2464372A2 (en) | Agent for stimulating mobilization of endothelial progenitor cells | |
| NI et al. | Accelerating Wound Repair: The Multifaceted Role of Mesenchymal Stem Cells | |
| CN119970606A (zh) | 一种毛囊组织活性维持营养液的制备方法 | |
| CN116982616A (zh) | 一种毛囊组织活性维持营养液的制备方法 | |
| PATHAKOTI | ROLE OF STEM CELLS IN REGENERATIVE MEDICINES & CARDIAC REPAIR | |
| HK1212888B (en) | Novel method for treating spinal cord injury using hmgb1 fragment | |
| HK1226601A1 (en) | Methods of using adipose tissue-derived cells in the treatment of raynaud’s phenomenon associated with scleroderma | |
| HK1226601B (en) | Methods of using adipose tissue-derived cells in the treatment of raynaud’s phenomenon associated with scleroderma | |
| HK1174356B (en) | Adherent cells from placenta and use of same in disease treatment |